The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kakorina E.P.

Sechenov University;
M.F. Vladimirsky Moscow Regional Research Clinical Institute

Samorodskaya I.V.

Moscow Regional Research Clinical Institute

The structure of causes of death of the adult population of the Moscow region in 2019 and 2023

Authors:

Kakorina E.P., Samorodskaya I.V.

More about the authors

Read: 726 times


To cite this article:

Kakorina EP, Samorodskaya IV. The structure of causes of death of the adult population of the Moscow region in 2019 and 2023. Russian Journal of Archive of Pathology. 2025;87(3):40‑48. (In Russ.)
https://doi.org/10.17116/patol20258703140

Recommended articles:
Immu­nology of the cervix in normal and pathological conditions (literature review). Russian Journal of Human Reproduction. 2024;(5):108-117
Intracranial hype­rtension in hemo­rrhagic stroke: a single-center retrospective study. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):23-29
COVID-19 and pneumonia — mortality and coding features (example of the Moscow region). Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):30-39
Endo­vascular treatment and sele­ction criteria for acute mese­nteric ischemia. Piro­gov Russian Journal of Surgery. 2025;(2):13-19
Lung tube­rculosis and mali­gnant neoplasms: the current state of the problem. Russian Journal of Preventive Medi­cine. 2025;(3):122-127

References:

  1. Schiltz NK. Prevalence of multimorbidity combinations and their association with medical costs and poor health: a population-based study of U.S. adults. Front Public Health. 2022;10:953886. https://doi.org/10.3389/fpubh.2022.953886
  2. Zhang X, Padhi A, Wei T, Xiong S, Yu J, Ye P, Tian W, Sun H, Peiris D, Praveen D, et al. Community prevalence and dyad disease pattern of multimorbidity in China and India: a systematic review. BMJ Glob Health. 2022;7(9):e008880. https://doi.org/10.1136/bmjgh-2022-008880
  3. Bishop K, Balogun S, Eynstone-Hinkins J, Moran L, Martin M, Banks E, Rao C, Joshy G. Analysis of multiple causes of death: a review of methods and practices. Epidemiology. 2023;34(3):333-344.  https://doi.org/10.1097/EDE.0000000000001597
  4. Drapkina OM, Samorodskaya IV, Cherkasov SN, Kakorina EP, Zairat’yants OV. Coding for causes of death: the need to address issues (consensus statement). Russian Journal of Preventive Medicine. 2021;24(9):66-73. (In Russ.). https://doi.org/10.17116/profmed20212409166
  5. Vaisman DSh. Rukovodstvo po ispol’zovaniyu Mezhdunarodnoi klassifikatsii boleznei v praktike vracha. 2 vol. 2nd ed. Moscow: Tsentral’nyi nauchno-issledovatel’skii institut organizatsii i informatizatsii; 2022. 514p. (In Russ.).
  6. Klevno VA, Zairat’yants OV, eds. Pravila formulirovki sudebno-meditsinskogo i patologoanatomicheskogo diagnozov, vybora i kodirovaniya prichin smerti po MKB-10. Rukovodstvo dlya vrachei. Moscow: GEOTAR-Media; 2023. 656p. (In Russ.).
  7. GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100-2132. https://doi.org/10.1016/S0140-6736(24)00367-2
  8. Feraldi A, Zarulli V. Patterns in age and cause of death contribution to the sex gap in life expectancy: a comparison among ten countries. Genus. 2022;78:23.  https://doi.org/10.1186/s41118-022-00171-9
  9. AIHW. How do causes of death vary by age? (Accessed 27.08.2024). https://www.aihw.gov.au/reports/life-expectancy-deaths/what-do-australians-die-from/contents/how-do-causes-of-death-vary-by-age.
  10. Samorodskaya IV, Semenov VYu. Mortality from arterial hypertension in the regions of the Russian Federation in the period from 2013 to 2019. Kardiologiya. 2021;61(12):59-65. (In Russ.). https://doi.org/10.18087/cardio.2021.12.n1643
  11. Asai K, Osugi Y. Increased mortality of “Died of Old Age” in Japan. J Gerontol Geriatr Med. 2022;8:135.  https://doi.org/10.24966/GGM-8662/100135
  12. Tkacheva ON, Kotovskaya YuV, Runikhina NK, Frolova EV, Naumov AV, Vorob’eva NM, Ostapenko VS, Mkhitaryan EA, Sharashkina NV, Tyukhmenev EA, Pereverzev AP, Dudinskaya EN. Senile asthenia: clinical recommendations. Russian Journal of Geriatric Medicine. 2020;(1):11-46. (In Russ.). https://doi.org/10.37586/2686-8636-1-2020-11-46
  13. Smirnova MI, Samorodskaya IV, Drapkina OM. Variability of death rates from respiratory diseases in the regions of the Russian Federation during the COVID-19 pandemic and the three previous years. Russian Journal of Preventive Medicine. 2024;27(4):82-88. (In Russ.) https://doi.org/10.17116/profmed20242704182
  14. Drapkina OM, Samorodskaya IV, Semenov VYu, Zairat’yants OV. Comparative analysis of variability of mortality rates from various causes in the subjects of Russian Federation. Russian Journal of Archive of Pathology. 2020;82(3):31-37. (In Russ.). https://doi.org/10.17116/patol20208203131
  15. Drapkina OM, Samorodskaya IV, Larina VN. Guidelines for the diagnosis and management of chronic coronary syndromes in primary health care — the issue of acceptability for the Russian Federation. Kardiologiya. 2020;60(4):130-136. (In Russ). https://doi.org/10.18087/cardio.2020.4.n1000
  16. Samorodskaya IV, Shepel’ RN, Kakorina EP, Drapkina OM. Chronic coronary artery disease: aspects of recording and coding in clinical practice (results of a survey of physicians). Cardiovascular Therapy and Prevention. 2024;23(5):4027. (In Russ.). https://doi.org/10.15829/1728-8800-2024-4027
  17. Januzzi JL, Del Prato S, Rosenstock J, Butler J, Ezekowitz J, Ibrahim NE, Lam CSP, Marwick T, Wilson Tang WH, Liu Y, et al. Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial. Cardiovasc Diabetol. 2024;23(1):49.  https://doi.org/10.1186/s12933-024-02135-z
  18. Ren J, Wu NN, Wang S, Sowers JR, Zhang Y. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101(4):1745-1807. https://doi.org/10.1152/physrev.00030.2020
  19. Vaisman DSh, Enina EN. Coronary artery disease mortality rates in the Russian Federation and in a number of regions: dynamics and structure specifics. Cardiovascular Therapy and Prevention. 2024;23(7):3975. (In Russ.). https://doi.org/10.15829/1728-8800-2024-3975
  20. Jang SC, Nam JH, Lee SA, An D, Kim HL, Kwon SH, Lee EK. Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis. Orphanet J Rare Dis. 2022;17(1):262.  https://doi.org/10.1186/s13023-022-02425-3
  21. Damy T, Bourel G, Slama M, Algalarrondo V, Lairez O, Fournier P, Costa J, Pelcot F, Farrugia A, Zaleski ID, et al. Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases. Orphanet J Rare Dis. 2023;18(1):345.  https://doi.org/10.1186/s13023-023-02933-w
  22. Moïsi L, Mino JC, Guidet B, Vallet H. Frailty assessment in critically ill older adults: a narrative review. Ann Intensive Care. 2024;14(1):93.  https://doi.org/10.1186/s13613-024-01315-0
  23. Samorodskaya IV, Kakorina EP, Chernyavskaya TK. Mortality from alcoholic cardiomyopathy: evidence and statistical problems. Russian Journal of Cardiology. 2023;28(11):5498. (In Russ.). https://doi.org/10.15829/1560-4071-2023-5498
  24. Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503-3626. https://doi.org/10.1093/eurheartj/ehad194

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.